Evaluating the Activity of Ultrasound on Biofilm Formation by Acinetobacter baumannii isolated from clinical Specimens
DOI:
https://doi.org/10.21123/bsj.2022.7739Abstract
Acinetobacter baumannii received attention for its multi-drug resistant associated with many severe infections and outbreaks in clinical environment. The aims of the study are to investigate the antibiotic susceptibility profile of clinically isolated A. baumannii, biofilm production, and the efficiency of Low Frequency Ultrasound (LFU) and honey to attenuate biofilm production. A total of 100 samples were taken from different sources from Baghdad hospitals. The susceptibility patterns revealed the percentage of pan drug resistant (PDR) isolates were 1.5 %, 72.7 % were extended drug resistant (XDR), 16.7 % were multidrug resistant (MDR), and 9.1 % were non MDR and sensitive to most antibiotics used. The ability to form biofilm was detected by crystal violet staining, and the results showed that 20% were strong biofilm, and 31.8% were moderate biofilm. The biofilm formation percentage was decreased using Low frequency ultrasound LFU and honey. Moreover, PCR results revealed that not all of them harbouring biofilm-related genes or integrons (bap, csuE, IntI-1, IntI-2), although, they are strong biofilm producers. These results conclude that low frequency ultrasound and chemical components of honey might be a good choice to restrain A. baumannii biofilm formation, and negative correlation between antibiotic resistance and biofilm ability.
Running title: Antimicrobial drug resistance, Acinetobacter baumannii, biofilm inhibition
Received 12/8/2022, Accepted 29/9/2022, Published Online First 25/11/2022
References
Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J Biol Sci. 2018 Mar 1; 25(3): 586-96. https://doi.org/10.1016/j.sjbs.2022.103437
Gedefie A, Demsis W, Ashagrie M, Kassa Y, Tesfaye M, Tilahun M, et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist. 2021 Sep 10; 14: 3711-3719. https://doi.org/10.2147/IDR.S386082
Subramaniyan A. Profile of multidrug resistant Acinetobacter baumannii infections among hospitalized patients. J Med Sci Clin. Res.. 2017; 5: 23111‑23115. https://dx.doi.org/10.18535/jmscr/v10i9.01
Liu AR, Du WJ, Xie JF, Xu JY, Huang YZ, Qiu HB, et al . Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice. Chin Med J .2020 Sep 20; 133(18) :2161-2169. https://dx.doi.org/10.1097/CM9.0000000000001835
Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018 Nov 15; 11: 2277-2299. https://doi.org/10.2147/IDR.S386082
Sharahi JY, Azimi T, Shariati A, Safari H, Tehrani MK, Hashemi A. Advanced strategies for combating bacterial biofilms. J Cell Physiol. 2019 Sep; 234(9): 14689-708. https://doi.org/10.1002/jcp.30880.
Mahmoudi A, Rezaei A, Poursina F, Faghri J . Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran Arch Clin Infect Dis .2019 Apr 30; 14(2): e85766.
Sato Y, Unno Y, Kawakami S, Ubagai T, Ono Y. Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps. J Med. Microbiol. 2017 Feb 1; 66(2): 203-12. https://dx.doi.org/10.5812/archcid-129169.
Pakharukova N, Tuittila M, Paavilainen S, Malmi H, Parilova O, Teneberg S, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci. U.S.A. 2018 May 22; 115(21): 5558-63. https://dx.doi.org/10.1073/iti1922119
Khalil MA, Ahmed FA, Elkhateeb AF, Mahmoud EE, Ahmed MI, Ahmed RI, et al . Virulence characteristics of biofilm-forming acinetobacter baumannii in clinical isolates using a Galleria Mellonella Model. Microorganisms. 2021 Nov 16; 9(11): 2365. https://doi.org/10.3390/microorganisms10102018
Shenkutie AM, Yao MZ, Siu GK, Wong BK, Leung PH. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii isolates. Antibiotics. 2020 Nov 17; 9(11): 817. doi: 10.3390/antibiotics9110817.
Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter Baumannii: genotype-phenotype correlation. Molecules. 2019 May 14; 24(10): 1849. https://dx.doi.org/ 10.3390/molecules24101849 .
Kataoka Y, Kunimitsu M, Nakagami G, Koudounas S, Weller CD, Sanada H. Effectiveness of ultrasonic debridement on reduction of bacteria and biofilm in patients with chronic wounds: A scoping review. Int Wound J. 2021 Apr; 18(2): 176-86. https://dx.doi.org/10.1111/iwj.13509 .
Kojima Y, Imazu H, Nishida K. Ultrasonics Sonochemistry Physical and chemical characteristics of ultrasonically-prepared water-in-diesel fuel: Effects of ultrasonic horn position and water content. Ultrason Sonochem. 2014; 21(2): 722-8. https://doi.org/10.1016/j.ultsonch.2013.09.019
Liu X, Wang J, Weng CX, Wang R, Cai Y. Low-frequency ultrasound enhances bactericidal activity of antimicrobial agents against Klebsiella pneumoniae biofilm. Biomed Res Int. 2020 Jan 3; 2020. https://dx.doi.org/10.1155/2020/5916260
Kanaan MH, Al-Shadeedi SM, Al-Massody AJ, Ghasemian A. Drug resistance and virulence traits of Acinetobacter baumannii from Turkey and chicken raw meat. Comp Immunol Microbiol Infect Dis. 2020 Jun 1; 70: 101451. https://dx.doi.org/10.1016/j.cimid.2020.101451 .
Lotfi F, Shojaie M, Rahbarnia L, Dehnad A, Naghili B, Lotfi H. Molecular characterization and genetic diversity of multidrug-and extensively drug-resistant A. baumannii clinical isolates. Gene Rep. 2022 Mar 1; 26: 101455. https://dx.doi.org/10.1016/j.genrep.2021.101455
Li Z, Ding Z, Liu Y, Jin X, Xie J, Li T, et al . Phenotypic and genotypic characteristics of biofilm formation in clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2021; 14: 2613. https://dx.doi.org/10.2147/IDR.S310081
Khoshnood S, Savari M, Montazeri EA, Sheikh AF. Survey on genetic diversity, biofilm formation, and detection of colistin resistance genes in clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2020; 13: 1547. https://dx.doi.org/10.2147/IDR.S253440 .
Bokaeian M, Shahraki Zahedani S, Soltanian Bajgiran M, Ansari Moghaddam A. Frequency of PER, VEB, SHV, TEM and CTX-M Genes in Resistant Strains of Pseudomonas aeruginosa Producing Extended Spectrum β-Lactamases. Jundishapur J Microbiol. 2014 Dec 8; 8(1): e13783. https://dx.doi.org/10.5812/jjm.13783 .
Gallagher SR. Quantitation of DNA and RNA with absorption and fluorescence spectroscopy. Curr Protoc Immunol. 2017 Feb; 116(1): A-3L. https://dx.doi.org/10.1002/cpim.20 .
Sobouti B, Mirshekar M, Fallah S, Tabaei A, Fallah Mehrabadi J, Darbandi A. Pan drug-resistant Acinetobacter baumannii causing nosocomial infections among burnt children. Med J Islam Repub Iran. 2020 Mar 23; 34: 24. https://dx.doi.org/10.34171/mjiri.34.24
Raro OH, Gallo SW, Ferreira CA, Oliveira SD. Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit. Revista da Sociedade Brasileira de Med Trop. 2017 Mar; 50: 167-72. https://dx.doi.org/10.1590/0037-8682-0329-2016 .
Göttig S, Gruber TM, Higgins PG, Wachsmuth M, Seifert H, Kempf VA. Detection of pan drug-resistant Acinetobacter baumannii in GermanyAntimicrob J Antimicrob Chemother. 2014 Sep 1; 69(9): 2578-9. doi: 10.1093/jac/dku170.
Omer MI, Gumaa SA, Hassan AA, Idris KH, Ali OA, Osman MM, et al. Prevalence and resistance profile of Acinetobacter baumannii clinical isolates from a private hospital in Khartoum, Sudan Am J Microbiol Res. 2015 Feb; 3(2): 76-9. https://dx.doi.org/10.12691/ajmr-3-2-6
Ghaima KK, Saadedin SM, Jassim KA. Isolation, molecular identification and antimicrobial susceptibility of Acinetobacter baumannii isolated from Baghdad hospitals. Burns 2015; 6(5): 351-356. http://dx.doi.org/10.21931/RB/2021.06.04.25
Abdumohsin BM, Al-Daraghi WA. Biochemical and Molecular Identification of Acinetobacter baumannii Isolated from Patients in Baghdad Hospitals. kerbala j pharm sci . 2020; (18): 72-80.
Rahbarnia L, Farajnia S, Khaneshi H, Farania H, Naghili B, Tanomand A. Detection of blaOXA-23 and blaNDM-1 carbapenemase among clinical isolates of A. baumannii in Tabriz, north-west of Iran Gene Rep. 2020 Mar 1; 18: 100555. DOI: 10.1016/j.genrep.2019.100555
Abd El-Baky RM, Farhan SM, Ibrahim RA, Mahran KM, Hetta HF. Antimicrobial resistance pattern and molecular epidemiology of ESBL and MBL producing Acinetobacter baumannii isolated from hospitals in Minia, Egypt. Alexandria J Med. 2020 Jan 1; 56(1): 4-13. https://doi.org/10.1080/20905068.2019.1707350
Beheshti M, Ardebili A, Beheshti F, Lari AR, Siyadatpanah A, Pournajaf A, et al . Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii. Revista do Instituto de Medicina Tropical de São Paulo. 2020 Nov 13; 62: e88. https://dx.doi.org/10.1590/S1678-9946202062088
Arjmand R, Porrostami K, Esteghamat SS, Chaghamirzayi P, Sharifian P, Zahmatkesh E, et al . Frequency and Antibiotic Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Infections in Pediatrics Intensive Care Unit of Imam Ali Hospital, Karaj, Iran During 2017-2018. Int J Enteric Path 2020 Feb 28; 8(1): 15-8.
Abbas SM, Dhahi MAR. Evaluation of some Virulence Factors and Drug Resistance of Bacteria Isolated from the Urine of Patients with TCC-Bladder Cancer. Baghdad Sci J. 2022Jun.1 [cited 2022Sep.16]; 19(3): 0469. https://doi.org/10.21123/bsj.2022.19.3.0469.
Dedeić-Ljubović A, Granov Đ, Hukić M. Emergence of extensive drug-resistant (XDR) Acinetobacter baumanniiin the Clinical Center University of Sarajevo, Bosnia and Herzegovina. Med Glas (Zenica) .2015 Aug 1; 12(2): 169-176. https://dx.doi.org/10.17392/809-15 .
MEKKEY AM, AL-OUBAIDY SA, ALZAIDI JR. Phenotypic and genotypic characterization of Acinetobacter baumannii Iraqi isolates. Int J Pharm Res. 2020 Jul; 12(2): 1-7. https://dx.doi.org/10.1016/j.micpath.2021.104922
Mohamed N, Jabber M, Al-Jumaa ZM. Biotyping of Acinetobacter baumannii Iraqi Isolates. Int J Med Sci.. 2020; 3(3): 70-81. https://isnra.net/index.php/ijms/article/view/343
Angoti G, Bandehpour M, Goudarzi H, Hajizadeh M, Zarringhalam Moghaddam M, Kouchaki A. Detection of efflux pump genes (adeA, adeB, adeC and abeM) in Acinetobacter baumannii isolated from hospitalize patients, North-west of Iran. Infect. epidemiol. microbiol. 2016 Oct 10; 2(4): 8-11. DOI: 10.18869/modares.iem.2.4.8
Ridha D, Ali M, Jassim K. Occurrence of Metallo-β-Lactamase Genes among Acinetobacter Baumannii Isolated from Different Clinical Samples. J Pure Appl Microbiol. 2019 Jun 1; 13: 1111-9.
Mohammed NS, Al-Haideri HH. Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro. Baghdad Sci J. 2022; 19(2): 255-270. DOI: https://doi.org/10.21123/bsj.2022.19.2.0255
Radhi SH, Al-Charrakh AH. Occurrence of MBLs and Carbapenemases among MDR and XDR Acinetobacter baumannii Isolated from Hospitals in Iraq. Indian J Public Health Res Dev. 2019 Jul; 10(7): 668.
Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al . Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016 Apr 12; 7: 483.
Lin MF, Lin YY, Lan CY. Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation. Peer J. 2020 May 28; 8: e9020. https://dx.doi.org/10.3389/fmicb.2016.00483 .
Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis. 2019 Dec; 19(1): 1-9. DOI:https://doi.org/10.1186/s12879-019-4272-
Duckhouse H, Mason TJ, Phull SS, Lorimer JP. The effect of sonication on microbial disinfection using hypochlorite. J ultsonch . 2004 May 1; 11(3-4): 173-6. https://dx.doi.org/10.1016/j.ultsonch.2004.01.031
Yu H, Liu Y, Li L, Guo Y, Xie Y, Cheng Y, et al. Ultrasound-involved emerging strategies for controlling foodborne microbial biofilms. Trends Food Sci Technol. 2020 Feb 1; 96: 91-101.
Dhar Y, Han Y. Current developments in biofilm treatments: wound and implant infections. Eng Reg. 2020 Jan 1; 1: 64-75. 10.1016/j.engreg.2020.07.003
Joyce E, Al‐Hashimi A, Mason TJ. Assessing the effect of different ultrasonic frequencies on bacterial viability using flow cytometry. J Appl Microbiol. 2011 Apr; 110(4): 862-870. https://dx.doi.org/10.1111/j.1365-2672.2011.04923.x
Cai Y, Wang J, Liu X, Wang R, Xia L. A review of the combination therapy of low frequency ultrasound with antibiotics. Biomed Res Int. 2017 Oct 16; 2017. https://doi.org/10.1155/2017/2317846
Zainol MI, Mohd Yusoff K, Mohd Yusof MY. Antibacterial activity of selected Malaysian honey. BMC complement. Med ther. .2013 Dec; 13(1): 1-10. DOI:https://doi.org/10.1186/1472-6882-13-129
Jibril FI, Hilmi AB, Manivannan L. Isolation and characterization of polyphenols in natural honey for the treatment of human diseases. Bull Natl Res Cent. 2019 Dec; 43(1): 1-9. https://doi.org/10.1186/s42269-019-0044-7
Al-kafaween MA, Hilmi AB, Jaffar N, Al-Jamal HA, Zahri MK, Jibril FI. Antibacterial and Antibiofilm activities of Malaysian Trigona honey against Pseudomonas aeruginosa ATCC 10145 and Streptococcus pyogenes ATCC 19615. Jordan J Biol Sci. 2020 Jun; 13(1): 69-76.
Colquhoun JM, Rather PN. Insights into mechanisms of biofilm formation in Acinetobacter baumannii and implications for uropathogenesis. Front Cell Infect. Microbiol. 2020 May 29; 10: 253. https://dx.doi.org/10.3389/fcimb.2020.00253 .
Fallah A, Rezaee MA, Hasani A, Barhaghi MH, Kafil HS. Frequency of bap and cpaA virulence genes in drug resistant clinical isolates of Acinetobacter baumannii and their role in biofilm formation. Iran J Basic Med Sci. 2017 Aug; 20(8): 849-855. https://dx.doi.org/10.22038/IJBMS.2017.9105
Saadati M, Rahbarnia L, Farajnia S, Naghili B, Mohammadzadeh R. The prevalence of biofilm encoding genes in multidrug-resistant Acinetobacter baumannii isolates. Gene Rep. 2021 Jun 1; 23: 101094. https://dx.doi.org/10.1016/j.genrep.2021.101094
Abbaszadeh F, Hasani A, Rezaee MA, Sadeghi J, Hasani A, Oskouee MA, et al . Genetic characterization of extensive drug resistant Acinetobacter baumannii: an appalling impediment. Folia Med. 2021 Oct 31; 63(5): 726-37. https://dx.doi.org/10.3897/folmed.63.e56566 .
Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie MR, Mansouri S, et al . Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant Acinetobacter baumannii. Rep Biochem Mol Biol. 2016 Oct; 5(1): 62.
Ghasemi E, Ghalavand Z, Goudarzi H, Yeganeh F, Hashemi A, Dabiri H, et al . Phenotypic and genotypic investigation of biofilm formation in clinical and environmental isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018 Aug 30; 13(4). https://dx.doi.org/10.5812/archcid.12914
Sung JY. Molecular characterization and antimicrobial susceptibility of biofilm-forming Acinetobacter baumannii clinical isolates from Daejeon, Korea. Korean J Clin Lab Sci.2018; 50(2): 100-9. https://doi.org/10.15324/kjcls.2018.50.2.100
Amin M, Navidifar T, Shooshtari FS, Rashno M, Savari M, Jahangirmehr F, et al . Association between biofilm formation, structure, and the expression levels of genes related to biofilm formation and biofilm-specific resistance of Acinetobacter baumannii strains isolated from burn infection in Ahvaz, Iran. Infect Drug Resist. 2019; 12: 3867–3881. doi: 10.2147/IDR.S228981.
Pormohammad A, Pouriran R, Azimi H, Goudarzi M. Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis. Iran. J Basic Med Sci.. 2019 Feb; 22(2): 118. https://dx.doi.org/10.22038/ijbms.2018.32052.7697
Ghazalibina M, Mortazavi H, Babadi M, Rahimi M, Khaledi A, Teymouri M, et al . Prevalence of integrons and antibiotic resistance pattern in Acinetobacter baumannii isolated from clinical samples of Iranian patients: A systematic review and meta-analysis. Ethiop J Health Sci. 2019; 29(5). https://dx.doi.org/10.4314/ejhs.v29i5.15
Halaji M, Rezaei A, Zalipoor M, Faghri J. Investigation of class I, II, and III integrons among Acinetobacter Baumannii isolates from hospitalized patients in Isfahan, Iran. Oman M J. 2018 Jan; 33(1): 37. https://dx.doi.org/10.5001/omj.2018.07
Ardoino I, Zangirolami F, Iemmi D, Lanzoni M, Cargnelutti M, Biganzoli E, et al . Risk factors and epidemiology of Acinetobacter baumannii infections in a university hospital in Northern Italy: A case-control study. Am J Infect Control, 2016 Dec 1; 44(12): 1600-5. 1 https://dx.doi.org/0.1016/j.ajic.2016.05.005.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Baghdad Science Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
